Biohaven Pharmaceutical Holding Company Ltd.

NY · United States · Reporting entity ID 100001106888

Total reported 2019–2025

$46.5M

#186 of 2,960 reporting companies — 0.1% of all reported industry payments

$13.4M in general payments across 220,463 records, plus $33.1M in research funding across 9,337 records.

How it breaks down

General payments $13,405,588

Research funding $33,075,271

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.